ABSTRACT
Objective To analyze the influence of different therapeutic environments on stigma of schizophrenia patients. Methods A total of 70 outpatients and 70 inpatients with schizophrenia in remission in Tongde hospital of Zhejiang province were enrolled and investigated by using Brief Psychiatric Rating Scale (BPRS),Positive and Negative Syndrome Scale (PANSS),Treatment Emergent Symptom Scale (TESS)and Clinician's Global Impressions-Severity of Illness Scale (CGI-SI).Results Both outpatients and inpatients had been discriminated and had the situation of stigma and disease concealing.After inpatient treatment,the scores of disease concealing factor and positive effect factor were 2.01 ±0.88 and 1.68 ±0.78 respectively,which were significantly lower than those of outpatients (2.43 ±0.98 and 2.44 ±0.78, respectively,P<0.05 ).Conclusion Outpatient treatment has the influence on reduce stigma and improve the life quality of schizophrenia patients in remission.
ABSTRACT
<p><b>OBJECTIVE</b>To compare the incidences of sexual dysfunction induced by mirtazapine and SSRI in the treatment of patients with depression.</p><p><b>METHODS</b>Using key-word retrieval from the compact disks of the Chinese biological medicine (CBM) data base, we analyzed the rates of sexual dysfunction from the published clinical control trials on depression treated with mirtazapine and SSRI by applying the fixed effects model (FEM) of evidence-based medicine (EBM).</p><p><b>RESULTS</b>Among 1108 cases in 14 studies, there were 5 cases of mirtazapine-induced and 106 cases of SSRI-induced sexual dysfunction, accounting for 0.90% and 19.2% respectively, OR = 0.07 (95% CI: 0.04-0.14), Z = 8.03, P < 0.01.</p><p><b>CONCLUSION</b>SSRI is far more likely to induce sexual dysfunction than mirtazapine in the treatment of depression.</p>